BMBS COST Action BM0606
Collaborative association studies in breast cancer
Descriptions are provided by the Actions directly via e-COST.
1. Main Objective The main objective of this Action is to provide reliable breast cancer risks associated with genetic variants, through collaborative epidemiological studies. Specifically, one aims to provide an evaluation of at least 60 genetic variants over the period of this Action. 2. Secondary objectives - To examine the combined effects of multiple risk factors. - To evaluate interactions between genetic and lifestyle risk factors. - To evaluate the evidence for genetic associations in particular subsets of breast cancer. - To examine evidence for associations between these variants and survival from breast cancer. - To facilitate exchange of expertise in genotyping technologies and analysis among participating countries. 3. Deliverables - Estimates of breast cancer risk, by age, associated with 60+ polymorphisms - Estimates of the combined effects of disease associated polymorphisms on breast cancer risk. - Risk estimates by genotype for each subtype of breast cancer. - Risk estimates by genotype and known lifestyle risk factors.
General Information*
Chair of the Action:
Prof. Peter DEVILEE (NL)
Vice Chair of the Action:
Dr Stig BOJESEN (DK)
DC Rapporteurs:
Prof. Aleksandar DIMOVSKI (MK)
Science officer of the Action:
Administrative officer of the Action:
Downloads*
Action Fact Sheet
Memorandum of Understanding
Progress Report
Download Progress Report as PDF
Poster
Websites*
* powered by e-COST
